Skip to main content
Premium Trial:

Request an Annual Quote

UK Cancer Institute Buys TTP LabTech's Microplate Cytometer

NEW YORK (GenomeWeb News) – TTP LabTech has sold a microplate cytometer to Cancer Research UK for an RNAi-based whole-genome screening program aimed at identifying cytotoxic survival regulators.
Cancer Research UK’s London Research Institute will use the Acumen eX3 cytometer at a new high-throughput screening facility that will provide researchers with access to genome-wide siRNA and RNAi screening technologies. TTP said the Acumen X3 can help to speed genome screening time, and that it can read a 384-well plate in less than ten minutes.
The research techniques at the LRI are used in a broad range of research areas, “from yeast to flies to human cells,” the company said. The institute’s research includes studies of signaling processes that can control the intrinsic properties of cancer cells and their interactions with hosts as well as how the genome holds its integrity through environmental and endogenous changes.
Financial terms of the agreement were not released.

The Scan

Follow-Up Data Requests to Biobank Participants Ineffective, Study Finds

An effort to recontact biobank enrollees for additional information reports low participation in a new BMJ Open study.

Study Finds Widespread Transmission of Resistant Bacteria in Vietnam Hospitals

A sequencing study in The Lancet Microbe finds widespread transmission of drug-resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii in two Vietnam ICUs.

Novel Brain Cell Organoids Show Promise for Autism Research

University of Utah researchers report in Nature Communications on their development of brain cell organoids to study SHANK3-related autism.

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.